BC
FLXN

Broadfin Capital’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Broadfin Capital’s Portfolio FLXN Stock Details FLXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-323,188
Closed -$4.8M – 101
2015
Q3 		$4.8M Sell
323,188
-25,016
-7% -$587K 0.38% 68
2015
Q2 		$7.62M Hold
348,204
– – 0.5% 56
2015
Q1 		$7.84M Sell
348,204
-65,000
-16% -$1.51M 0.63% 46
2014
Q4 		$8.34M Buy
413,204
+200,000
+94% +$3.62M 0.73% 38
2014
Q3 		$3.89M Sell
213,204
-50,000
-19% -$724K 0.41% 52
2014
Q2 		$3.55M Hold
263,204
– – 0.35% 58
2014
Q1 		$4.33M Buy
+263,204
New +$4.55M 0.42% 57

Other funds holding FLXN

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
KCM
Kingdon Capital Management New York $597M AUM 51.11% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return